Novedades en la sífilis congénita: perspectivas epidemiológicas, microbiológicas y clínicas
Revista Latinoamericana de Infectología Pediátrica · 2024 · 37 (2) · 67-75
DOI: 10.35366/117222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Latinoamericana de Infectología Pediátrica, 2024. Verfasst von María Ríos-Barnés und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Syphilis is mainly a sexually-transmitted infection caused byTreponema pallidum that remains a significant public health issue worldwide, with an increasing incidence at a global level.This contributes to elevated rates of congenital syphilis in low-and middle-income countries and to the resurgence of the disease in high-income countries in recent years.However, the true disease burden of syphilis in pregnant women and congenital syphilis is uncertain.It is imperative to strengthen healthcare systems to ensure access to screening and treatment for all pregnant individuals, their children, and their sexual partners, as well as to boost surveillance networks to effectively address interventions in congenital syphilis.
Zitieren
APA
Ríos-Barnés, M., Noguera-Julian, A., & Fortuny, C. (2024). Novedades en la sífilis congénita: perspectivas epidemiológicas, microbiológicas y clínicas. Revista Latinoamericana de Infectología Pediátrica, 37(2), 67-75. https://doi.org/10.35366/117222
Vancouver
Ríos-Barnés M, Noguera-Julian A, Fortuny C. Novedades en la sífilis congénita: perspectivas epidemiológicas, microbiológicas y clínicas. Revista Latinoamericana de Infectología Pediátrica. 2024;37(2):67-75. doi:10.35366/117222
BibTeX
@article{RosBarns2024,
author = {Ríos-Barnés, María and Noguera-Julian, Antoni and Fortuny, Clàudia},
title = {Novedades en la sífilis congénita: perspectivas epidemiológicas, microbiológicas y clínicas},
journal = {Revista Latinoamericana de Infectología Pediátrica},
year = {2024},
volume = {37},
number = {2},
pages = {67--75},
doi = {10.35366/117222}
}
EUVIMED